Ellsworth Advisors’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,131	Closed	-$414K	–	162
2021 Q1	$414K	Buy	3,131 +389	+14%	+$51.4K	0.25%	84
2020 Q4	$474K	Buy	2,742 +401	+17%	+$69.3K	0.34%	69
2020 Q3	$261K	Buy	+2,341	New	+$261K	0.26%	71